{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:15:57Z","timestamp":1787969757135,"version":"build-2784847793"},"reference-count":191,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1097\/01.crd.0000102420.62200.e1","type":"journal-article","created":{"date-parts":[[2004,6,10]],"date-time":"2004-06-10T04:02:12Z","timestamp":1086840132000},"page":"201-221","source":"Crossref","is-referenced-by-count":69,"title":["Cardiovascular Pharmacotherapeutic Considerations During Pregnancy and Lactation"],"prefix":"10.1097","volume":"12","author":[{"given":"Shadi A.","family":"Qasqas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Elkayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance.","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/gut.7.6.612","article-title":"Effects of oestrogens and progestogens on gastric secretion in patients with duodenal ulcer.","volume":"7","author":"Parbhoo","year":"1966","journal-title":"Gut"},{"key":"R3-6-20210203","article-title":"Pharmacokinetic Basis for Drug Treatment.","author":"Parker","year":"1984"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0733-8651(18)30519-8","article-title":"Cardiovascular drugs in pregnancy.","volume":"5","author":"Widerhorn","year":"1987","journal-title":"Cardiol Clin"},{"key":"R5-6-20210203","article-title":"Current Reviews in Obstetrics and Gynecology.","author":"Krauer","year":"1984"},{"key":"R6-6-20210203","article-title":"Medical Complications During Pregnancy, 5th ed.","author":"Burrow","year":"1999"},{"key":"R7-6-20210203","first-page":"11","article-title":"Burwell and Metcalfe's Heart Disease and Pregnancy: Physiology and Management, 2nd ed.","author":"Metcalfe","year":"1986"},{"key":"R8-6-20210203","first-page":"37","article-title":"Normal cardiopulmonary adjustments to pregnancy: cardiovascular evaluation.","volume":"19","author":"Cole","year":"1989","journal-title":"Cardiovasc Clin"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000457284","article-title":"Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol.","volume":"6","author":"Herngren","year":"1983","journal-title":"Dev Pharmacol Ther"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1981.73","article-title":"Changes in plasma drug binding and \u03b11-acid glycoprotein in mother and newborn infant.","volume":"29","author":"Wood","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R11-6-20210203","first-page":"50","article-title":"Anesthesia for Obstetrics.","author":"Ralston","year":"1987"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-98-4-487","article-title":"Antiarrhythmic drug therapy during pregnancy.","volume":"98","author":"Rotmensch","year":"1983","journal-title":"Ann Intern Med"},{"key":"R13-6-20210203","first-page":"3","article-title":"Cardiac Problems in Pregnancy, 3rd ed.","author":"Elkayam","year":"1998"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.1981.tb00929.x","article-title":"Serial changes in renal haemodynamics during normal human pregnancy.","volume":"88","author":"Dunlop","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0009-9236(97)90118-1","article-title":"Induction of CYP2D6 in pregnancy.","volume":"62","author":"Wadelius","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 5","key":"R16-6-20210203","first-page":"9S","article-title":"Pharmacokinetics of fetal and neonatal exposure to drugs.","volume":"58","author":"Levy","year":"1981","journal-title":"Obstet Gynecol"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00006254-197909000-00001","article-title":"Drugs in pregnancy.","volume":"34","author":"Howard","year":"1979","journal-title":"Obstet Gynecol Surv"},{"issue":"suppl 5","key":"R18-6-20210203","first-page":"3S","article-title":"In vivo assessment of the teratogenic potential of drugs in humans.","volume":"58","author":"Stern","year":"1981","journal-title":"Obstet Gynecol"},{"issue":"suppl 5","key":"R19-6-20210203","first-page":"17S","article-title":"Pharmacologic considerations of drug use in the lactating mother.","volume":"58","author":"Berlin","year":"1981","journal-title":"Obstet Gynecol"},{"key":"R20-6-20210203","first-page":"501","article-title":"Passage of drugs across body membranes.","volume":"14","author":"Schanker","year":"1962","journal-title":"Pharmacol Gynecol"},{"key":"R21-6-20210203","first-page":"157","article-title":"Handbook of Clinical Drug Data, 6th ed.","author":"Anderson","year":"1988"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3181\/00379727-80-19682","article-title":"Placental transfer of radioactive digitoxin in rats and guinea pigs.","volume":"80","author":"Okita","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0773.1980.tb02454.x","article-title":"Placental transmission and foetal distribution of 3H-ouabain.","volume":"46","author":"Saarikoski","year":"1980","journal-title":"Acta Pharmacol Toxicol"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM197211162872003","article-title":"Serum digoxin concentrations in the human fetus, neonate and infant.","volume":"287","author":"Rogers","year":"1972","journal-title":"N Engl J Med"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0002-9149(60)90235-6","article-title":"Transplacental neonatal digitalis intoxication.","volume":"6","author":"Sherman","year":"1960","journal-title":"Am J Cardiol"},{"key":"R26-6-20210203","first-page":"81","article-title":"Congenital rhabdomyoma of the heart and intrauterine digitalis poisoning.","volume":"11","author":"Potondi","year":"1967","journal-title":"J Forensic Sci"},{"key":"R27-6-20210203","first-page":"E38","article-title":"[3H] ouabain binding and Na+, K+-ATPase activity in human placenta.","volume":"238","author":"Whitsett","year":"1980","journal-title":"Am J Physiol"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/bmj.3.5879.519","article-title":"Influence of digitalis on time of onset and duration of labour in women with cardiac disease.","volume":"3","author":"Weaver","year":"1973","journal-title":"BMJ"},{"key":"R29-6-20210203","first-page":"426","article-title":"Cardiac Problems in Pregnancy, 3rd ed.","author":"Steinberg","year":"1998"},{"key":"R30-6-20210203","first-page":"893","article-title":"Cardiovascular Pharmacotherapeutics, 2nd ed.","author":"Gewitz","year":"2003"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0889-8545(05)70297-7","article-title":"Management of fetal cardiac arrhythmias.","volume":"24","author":"Copel","year":"1997","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0095-5108(18)30331-2","article-title":"Drug therapy for fetal arrhythmias.","volume":"21","author":"Ito","year":"1994","journal-title":"Clin Perinatol"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.66.5.1124","article-title":"Intrauterine and postnatal atrial fibrillation in the Wolff-Parkinson-White syndrome.","volume":"66","author":"Belhassen","year":"1982","journal-title":"Circulation"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0022-3476(78)80391-6","article-title":"Digoxin excretion in human breast milk.","volume":"92","author":"Loughnan","year":"1978","journal-title":"J Pediatr"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003495-197815040-00003","article-title":"Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.","volume":"15","author":"Anderson","year":"1978","journal-title":"Drugs"},{"key":"R36-6-20210203","first-page":"730","article-title":"Fetal supraventricular tachycardia in utero therapy with digoxin and quinidine.","volume":"64","author":"Spinnato","year":"1984","journal-title":"Obstet Gynecol"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9149(87)90823-X","article-title":"Association of atrial flutter with orthodromic reciprocating fetal tachycardia.","volume":"59","author":"Johnson","year":"1987","journal-title":"Am J Cardiol"},{"key":"R38-6-20210203","first-page":"15","article-title":"Manual of Medical Therapeutics, 28th ed.","author":"Whelan","year":"1995"},{"key":"R39-6-20210203","first-page":"366","article-title":"The use of quinidine sulfate throughout pregnancy.","volume":"54","author":"Hill","year":"1979","journal-title":"Obstet Gynecol"},{"key":"R40-6-20210203","first-page":"373","article-title":"Cardiac Problems in Pregnancy, 3rd ed.","author":"Shotan","year":"1998"},{"key":"R41-6-20210203","first-page":"284","article-title":"Drugs in Pregnancy and Lactation. A Reference Guide to Fetal and Neonatal Risk, 4th ed.","author":"Rosa","year":"1994"},{"key":"R42-6-20210203","first-page":"933","article-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th ed.","author":"Roden","year":"2001"},{"key":"R42A-6-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1542\/peds.93.1.137","article-title":"The transfer of drugs and other chemicals into human milk.","volume":"93","year":"1994","journal-title":"Pediatrics"},{"key":"R43-6-20210203","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM198210283071806","article-title":"Transplacental cardioversion of fetal supraventricular tachycardia with procainamide.","volume":"307","author":"Dumesic","year":"1982","journal-title":"N Engl J Med"},{"key":"R44-6-20210203","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0002-9149(84)91257-8","article-title":"Procainamide cardioversion of fetal supraventricular tachyarrhythmia.","volume":"53","author":"Given","year":"1984","journal-title":"Am J Cardiol"},{"key":"R45-6-20210203","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-2007-999246","article-title":"In utero conversion of supraventricular tachycardia with digoxin and procainamide at 17 weeks\u2019 gestation.","volume":"9","author":"Battiste","year":"1992","journal-title":"Am J Perinatol"},{"key":"R46-6-20210203","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0022-3476(83)80210-8","article-title":"Procainamide excretion in human milk.","volume":"102","author":"Pittard","year":"1983","journal-title":"J Pediatr"},{"key":"R47-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198005010-00001","article-title":"Drug excretion in human breast milk: principles, pharmacokinetics, and projected consequences.","volume":"5","author":"Wilson","year":"1980","journal-title":"Clin Pharmacokinet"},{"key":"R48-6-20210203","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/j.1552-4604.1978.tb02449.x","article-title":"Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.","volume":"18","author":"Luoma","year":"1978","journal-title":"J Clin Pharmacol"},{"key":"R49-6-20210203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1185\/03007997909109400","article-title":"Disopyramide in pregnancy: a case report.","volume":"6","author":"Shaxted","year":"1979","journal-title":"Curr Med Res Opin"},{"key":"R50-6-20210203","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1056\/NEJM197807132990207","article-title":"Initiation of uterine contractions by disopyramide during pregnancy.","volume":"299","author":"Leonard","year":"1978","journal-title":"N Engl J Med"},{"key":"R51-6-20210203","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0002-9378(90)90416-5","article-title":"The effect of disopyramide on uterine contractions during pregnancy.","volume":"162","author":"Tadmor","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R52-6-20210203","first-page":"653","article-title":"Preterm labor and accidental hemorrhage after disopyramide therapy in pregnancy. A case report.","volume":"44","author":"Abbi","year":"1999","journal-title":"J Reprod Med"},{"key":"R53-6-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.1990.tb03660.x","article-title":"Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.","volume":"29","author":"Echizen","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"R54-6-20210203","first-page":"56","article-title":"Disopyramide and N-monodesalkyl-disopyramide in serum and breast milk.","volume":"23","author":"Ellsworth","year":"1989","journal-title":"Drug Intell Clin Pharm"},{"key":"R55-6-20210203","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2125.1982.tb01985.x","article-title":"Disopyramide and its N-monodesalkyl metabolite in breast milk.","volume":"14","author":"Barnett","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"R56-6-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-197806000-00006","article-title":"Placental transfer of lidocaine: effects of fetal acidosis.","volume":"48","author":"Biehl","year":"1978","journal-title":"Anesthesiology"},{"key":"R57-6-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000542-198908000-00024","article-title":"Continuous epidural lidocaine infusion in the parturient with paroxysmal ventricular tachycardia.","volume":"71","author":"Juneja","year":"1989","journal-title":"Anesthesiology"},{"key":"R58-6-20210203","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00000542-197009000-00006","article-title":"Binding of anilide-type local anesthetics in human plasma. II. Implications in vivo, with special reference to transplacental distribution.","volume":"33","author":"Tucker","year":"1970","journal-title":"Anesthesiology"},{"key":"R59-6-20210203","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00000542-196809000-00017","article-title":"Plasma levels of lidocaine (Xylocaine) in mother and newborn following obstetrical conduction anesthesia: clinical applications.","volume":"29","author":"Shnider","year":"1968","journal-title":"Anesthesiology"},{"key":"R60-6-20210203","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00000542-197506000-00014","article-title":"Newborn blood levels of lidocaine and mepivacaine in the first postnatal day following maternal epidural anesthesia.","volume":"42","author":"Brown","year":"1975","journal-title":"Anesthesiology"},{"key":"R61-6-20210203","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00000542-196809000-00016","article-title":"The kinetics of transfer of lidocaine (Xylocaine) across the human placenta.","volume":"29","author":"Shnider","year":"1968","journal-title":"Anesthesiology"},{"key":"R62-6-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cpt1979262213","article-title":"Maternal, fetal, and neonatal metabolism of lidocaine.","volume":"26","author":"Kuhnert","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"R63-6-20210203","first-page":"643","article-title":"Lidocaine intoxication in a newborn following local anesthesia for episiotomy.","volume":"64","author":"Kim","year":"1979","journal-title":"Pediatrics"},{"key":"R64-6-20210203","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF02072637","article-title":"Episiotomy and neonatal lidocaine intoxication.","volume":"150","author":"De Praeter","year":"1991","journal-title":"Eur J Pediatr"},{"key":"R65-6-20210203","first-page":"27","article-title":"Acidosis, local anesthetics, and the newborn.","volume":"48","author":"Brown","year":"1976","journal-title":"Obstet Gynecol"},{"key":"R66-6-20210203","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1213\/00000539-197807000-00019","article-title":"Effects of pH on protein binding of lidocaine.","volume":"57","author":"Burney","year":"1978","journal-title":"Anesth Analg"},{"key":"R67-6-20210203","doi-asserted-by":"crossref","first-page":"A403","DOI":"10.1097\/00000542-198209001-00403","article-title":"Neonatal neuro-behavioral responses after epidural anesthesia for cesarean section with lidocaine and bupivacaine.","volume":"57","author":"Kileff","year":"1983","journal-title":"Anesthesiology"},{"key":"R68-6-20210203","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00000542-197610000-00008","article-title":"Neurobehavioral responses and drug concentrations in newborns after maternal epidural anesthesia with bupivacaine.","volume":"45","author":"Scanlon","year":"1976","journal-title":"Anesthesiology"},{"key":"R69-6-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM198701013160106","article-title":"Mexiletine.","volume":"316","author":"Campbell","year":"1987","journal-title":"N Engl J Med"},{"key":"R70-6-20210203","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(80)90319-0","article-title":"Mexiletine for control of ventricular dysrhythmias in pregnancy.","volume":"2","author":"Timmis","year":"1980","journal-title":"Lancet"},{"key":"R71-6-20210203","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9378(87)80191-6","article-title":"Mexiletine use in pregnancy and lactation.","volume":"157","author":"Lownes","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"R72-6-20210203","first-page":"33","article-title":"Mexiletine use in pregnancy.","volume":"8","author":"Gregg","year":"1988","journal-title":"J Perinatol"},{"key":"R73-6-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.288.6417.606","article-title":"Paranoid psychosis induced by tocainide.","volume":"288","author":"Currie","year":"1984","journal-title":"BMJ"},{"key":"R74-6-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003495-198326020-00001","article-title":"Tocainide: a review of its pharmacological properties and therapeutic efficacy.","volume":"26","author":"Holmes","year":"1983","journal-title":"Drugs"},{"key":"R75-6-20210203","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM198607033150107","article-title":"Tocainide.","volume":"315","author":"Roden","year":"1986","journal-title":"N Engl J Med"},{"key":"R77-6-20210203","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/hrt.67.3.266","article-title":"Incessant atrial tachycardia accelerated by pregnancy.","volume":"67","author":"Doig","year":"1992","journal-title":"Br Heart J"},{"key":"R78-6-20210203","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0002-8703(05)80306-0","article-title":"Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk.","volume":"119","author":"Wagner","year":"1990","journal-title":"Am Heart J"},{"key":"R79-6-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.296.6617.249","article-title":"Maternal administration of flecainide to terminate and suppress fetal tachycardia.","volume":"296","author":"Wren","year":"1988","journal-title":"BMJ"},{"key":"R80-6-20210203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/hrt.65.1.46","article-title":"Flecainide in the treatment of fetal tachycardias.","volume":"65","author":"Allan","year":"1991","journal-title":"Br Heart J"},{"key":"R81-6-20210203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3476(05)80509-8","article-title":"Fetal supraventricular tachycardia treated with flecainide acetate.","volume":"118","author":"Perry","year":"1991","journal-title":"J Pediatr"},{"key":"R82-6-20210203","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1297-9589(00)00003-5","article-title":"Fetal arrhythmias: diagnosis, prognosis, treatment; apropos of 33 cases.","volume":"28","author":"Vautier-Rit","year":"2000","journal-title":"Gynecol Obstet Fertil"},{"key":"R83-6-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00002018-199920010-00008","article-title":"Treatment of cardiac arrhythmias during pregnancy: safety considerations.","volume":"20","author":"Joglar","year":"1999","journal-title":"Drug Saf"},{"key":"R84-6-20210203","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-0528.1988.tb06517.x","article-title":"Fetal supraventricular tachycardia: detection by routine auscultation and successful in-utero management. Case report.","volume":"95","author":"Macphail","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"R85-6-20210203","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2125.1988.tb03413.x","article-title":"Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient.","volume":"26","author":"Brunozzi","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"R86-6-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1991.tb03945.x","article-title":"Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk.","volume":"32","author":"Libardoni","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"R87-6-20210203","first-page":"67","article-title":"Cardiovascular Pharmacotherapeutics, 2nd ed.","author":"Frishman","year":"2003"},{"key":"R88-6-20210203","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1471-0528.1978.tb14909.x","article-title":"Propranolol for the treatment of hypertension in pregnancy.","volume":"85","author":"Eliahou","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"R89-6-20210203","first-page":"127","article-title":"Adrenergic beta-receptor blockers in hypertension of pregnancy.","volume":"B1","author":"Sandstrom","year":"1982","journal-title":"Clin Exp Hypertens"},{"key":"R90-6-20210203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.CIR.97.5.451","article-title":"Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome.","volume":"97","author":"Rashba","year":"1998","journal-title":"Circulation"},{"key":"R91-6-20210203","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00016349109007160","article-title":"Treatment of hyperthyroidism in pregnancy.","volume":"70","author":"Sherif","year":"1991","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R92-6-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.4.5626.281","article-title":"Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy.","volume":"4","author":"Turner","year":"1968","journal-title":"BMJ"},{"key":"R93-6-20210203","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0002-9149(78)90916-5","article-title":"Effect of propranolol on fetal tachycardia in diabetic pregnancy.","volume":"42","author":"Teuscher","year":"1978","journal-title":"Am J Cardiol"},{"key":"R94-6-20210203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1471-0528.1980.tb04502.x","article-title":"Propranolol and hydralazine in the management of essential hypertension in pregnancy.","volume":"87","author":"Bott-Kanner","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"R95-6-20210203","first-page":"1309","article-title":"Cardiovascular Pharmacotherapeutics.","author":"Ngo","year":"1997"},{"key":"R96-6-20210203","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF00556896","article-title":"Pharmacokinetics of propranolol during pregnancy.","volume":"27","author":"O'Hare","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"R97-6-20210203","first-page":"341","article-title":"Propranolol in pregnancy: three year prospective study.","volume":"2","author":"Livingstone","year":"1983","journal-title":"Clin Exp Hypertens"},{"key":"R98-6-20210203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/pgmj.57.669.427","article-title":"Antihypertensive therapy with propranolol during pregnancy and lactation.","volume":"57","author":"Taylor","year":"1981","journal-title":"Postgrad Med J"},{"key":"R99-6-20210203","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-3476(75)80236-8","article-title":"Propranolol administration during pregnancy: effects on the fetus.","volume":"86","author":"Gladstone","year":"1975","journal-title":"J Pediatr"},{"key":"R100-6-20210203","first-page":"792","article-title":"The effect of propranolol on the onset of breathing at birth.","volume":"41","author":"Tunstall","year":"1969","journal-title":"Br J Anaesth"},{"key":"R101-6-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9378(79)90436-8","article-title":"Long-term propranolol therapy in pregnancy: maternal and fetal outcome.","volume":"135","author":"Pruyn","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"R102-6-20210203","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-0528.1991.tb13387.x","article-title":"The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.","volume":"98","author":"Blake","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"R103-6-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007691-198303000-00008","article-title":"Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma.","volume":"5","author":"Smith","year":"1983","journal-title":"Ther Drug Monit"},{"key":"R104-6-20210203","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9378(76)90698-0","article-title":"Effects of propranolol infusion on the umbilical and uterine circulations of pregnant sheep.","volume":"126","author":"Oakes","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"R105-6-20210203","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1136\/bmj.1.6180.1749","article-title":"Management of pregnancy in patients with hypertrophic cardiomyopathy.","volume":"1","author":"Oakley","year":"1979","journal-title":"BMJ"},{"key":"R106-6-20210203","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-3476(77)81049-4","article-title":"Propranolol therapy during pregnancy, labor and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition.","volume":"91","author":"Cottrill","year":"1977","journal-title":"J Pediatr"},{"key":"R107-6-20210203","first-page":"222","article-title":"Excretion of propanolol in human breast milk.","volume":"34","author":"Karlberg","year":"1974","journal-title":"Acta Pharmacol Toxicol"},{"key":"R108-6-20210203","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0002-9149(79)90090-0","article-title":"Propranolol in human plasma and breast milk.","volume":"43","author":"Bauer","year":"1979","journal-title":"Am J Cardiol"},{"key":"R109-6-20210203","first-page":"357","article-title":"Cardiac Problems in Pregnancy, 3rd ed.","author":"Hurst","year":"1998"},{"key":"R110-6-20210203","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0002-9378(85)90559-9","article-title":"Neonatal effects of maternal nadolol therapy.","volume":"152","author":"Fox","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"R111-6-20210203","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2125.1981.tb01232.x","article-title":"Nadolol in human serum and breast milk.","volume":"12","author":"Devlin","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"R112-6-20210203","first-page":"765","article-title":"Drugs in Pregnancy and Lactation. A Reference Guide to Fetal and Neonatal Risk, 5th ed.","author":"Briggs","year":"1998"},{"key":"R113-6-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0301-2115(95)02197-F","article-title":"Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study.","volume":"62","author":"Rasanen","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R114-6-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0020-7292(86)90015-9","article-title":"Management of pregnancy-induced hypertension with pindolol-comparative study with methyldopa.","volume":"24","author":"Ellenbogen","year":"1986","journal-title":"Int J Gynaecol Obstet"},{"issue":"suppl 2","key":"R115-6-20210203","doi-asserted-by":"crossref","first-page":"375S","DOI":"10.1111\/j.1365-2125.1982.tb01944.x","article-title":"Treatment of hypertension in pregnancy with \u03b2-adrenoceptor antagonist.","volume":"13","author":"Dubois","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"R116-6-20210203","article-title":"Mosby's GenRx, 11th ed.","author":"Schrefer","year":"2001"},{"issue":"suppl","key":"R117-6-20210203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00016348409157125","article-title":"Disposition of the adrenergic blocker metoprolol in the late pregnant woman, the amniotic fluid, the cord blood, and the neonate.","volume":"118","author":"Lindeberg","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R118-6-20210203","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/clpt.1985.114","article-title":"Pregnancy-induced increase in metoprolol metabolism.","volume":"37","author":"Hogstedt","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"R119-6-20210203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000292411","article-title":"Management of supraventricular tachycardia during hexoprenaline therapy for preterm labour: benefit of cardioselective beta blockade?","volume":"39","author":"Frigo","year":"1995","journal-title":"Gynecol Obstet Invest"},{"key":"R120-6-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0020-7292(82)90128-X","article-title":"Maternal anti-hypertensive therapy with beta-blockers associated with poor outcome in very low-birth weight infants.","volume":"38","author":"Kaaja","year":"1992","journal-title":"Int J Gynaecol Obstet"},{"key":"R121-6-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2125.1982.tb01974.x","article-title":"Atenolol in the treatment of essential hypertension during pregnancy.","volume":"14","author":"Rubin","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"R122-6-20210203","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/adc.59.11.1061","article-title":"First year of life after the use of atenolol in pregnancy associated hypertension.","volume":"59","author":"Reynolds","year":"1984","journal-title":"Arch Dis Child"},{"key":"R123-6-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","article-title":"Atenolol and fetal growth in pregnancies complicated by hypertension.","volume":"12","author":"Lydakis","year":"1999","journal-title":"Am J Hypertens"},{"key":"R124-6-20210203","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0890-6238(97)00021-X","article-title":"Antenatal exposure to atenolol and retroperitoneal fibromatosis.","volume":"11","author":"Satge","year":"1997","journal-title":"Reprod Toxicol"},{"key":"R125-6-20210203","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/j.1875-9114.1998.tb03906.x","article-title":"Pharmacokinetic and pharmacodynamic evaluation of atenolol during and after pregnancy.","volume":"18","author":"Hurst","year":"1998","journal-title":"Pharmacotherapy"},{"key":"R126-6-20210203","first-page":"725","article-title":"Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.","volume":"93","author":"Easterling","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R127-6-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis.","volume":"355","author":"von Dadelszen","year":"2000","journal-title":"Lancet"},{"key":"R128-6-20210203","first-page":"487","article-title":"A comparison of acebutolol with methyldopa in hypertensive pregnancy.","volume":"3","author":"Williams","year":"1983","journal-title":"Pharmatherapeutica"},{"key":"R129-6-20210203","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/BF00608227","article-title":"To nurse when receiving acebutolol: is it dangerous for the neonate?","volume":"30","author":"Boutroy","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R130-6-20210203","first-page":"277","article-title":"Short-acting beta-adrenergic blockade and the fetus. A case report.","volume":"37","author":"Gilson","year":"1992","journal-title":"J Reprod Med"},{"key":"R131-6-20210203","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.1980.tb04618.x","article-title":"Sotalol as a hypotensive agent in pregnancy.","volume":"87","author":"O'Hare","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"R132-6-20210203","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1651-2227.1998.tb01508.x","article-title":"Foetal supraventricular tachycardia treated with sotalol.","volume":"87","author":"Sonesson","year":"1998","journal-title":"Acta Paediatr"},{"key":"R133-6-20210203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(99)00589-6","article-title":"Atrial flutter in the perinatal age group: diagnosis, management and outcome.","volume":"35","author":"Lisowski","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R134-6-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2125.1990.tb03635.x","article-title":"Excretion of sotalol in breast milk [Letter].","volume":"29","author":"Hackett","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"R135-6-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(99)00288-3","article-title":"Maternal blood pressure and birthweight.","volume":"355","author":"de Swiet","year":"2000","journal-title":"Lancet"},{"key":"R136-6-20210203","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0002-9149(83)90377-6","article-title":"Amiodarone therapy during pregnancy.","volume":"51","author":"McKenna","year":"1983","journal-title":"Am J Cardiol"},{"key":"R137-6-20210203","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(83)92853-2","article-title":"Amiodarone in pregnancy.","volume":"1","author":"Pitcher","year":"1983","journal-title":"Lancet"},{"key":"R138-6-20210203","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/0002-8703(89)90028-8","article-title":"Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.","volume":"118","author":"Gembruch","year":"1989","journal-title":"Am Heart J"},{"key":"R138A-6-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0002-9149(87)80095-4","article-title":"Amiodarone and digoxin for refractory fetal tachycardia.","volume":"59","author":"Arnour","year":"1987","journal-title":"Am J Cardiol"},{"key":"R139-6-20210203","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0002-9149(85)90596-X","article-title":"Amiodarone in pregnancy.","volume":"56","author":"Penn","year":"1985","journal-title":"Am J Cardiol"},{"key":"R140-6-20210203","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pd.1970120903","article-title":"Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.","volume":"12","author":"Valensise","year":"1992","journal-title":"Prenat Diagn"},{"key":"R140A-6-20210203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ehj\/9.1.106","article-title":"Amiodarone during pregnancy.","volume":"9","author":"Strunge","year":"1988","journal-title":"Eur Heart J"},{"key":"R141-6-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/pgmj.61.711.75","article-title":"Use of amiodarone during pregnancy.","volume":"61","author":"Robson","year":"1985","journal-title":"Postgrad Med J"},{"key":"R142-6-20210203","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1651-2227.1988.tb10717.x","article-title":"Congenital hypothyroidism goiter and amiodarone.","volume":"77","author":"DeWolf","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"R143-6-20210203","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0002-8703(91)90489-5","article-title":"Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy.","volume":"122","author":"Widerhorn","year":"1991","journal-title":"Am Heart J"},{"key":"R144-6-20210203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9149(87)91070-8","article-title":"Neonatal hypothyroidism after treatment by amiodarone during pregnancy.","volume":"60","author":"Laurent","year":"1987","journal-title":"Am J Cardiol"},{"key":"R145-6-20210203","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0002-9378(95)91498-6","article-title":"Pregnancy outcome after gestational exposure to amiodarone in Canada.","volume":"172","author":"Magee","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R146-6-20210203","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pd.1970140819","article-title":"Fetal hypothyroidism as a complication of amiodarone treatment of persistent fetal supraventricular tachycardia.","volume":"14","author":"De Catte","year":"1994","journal-title":"Prenat Diagn"},{"key":"R147-6-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.1992.2.279","article-title":"Outcome of thyroid function in newborns from mothers treated with amiodarone.","volume":"2","author":"Matsumura","year":"1992","journal-title":"Thyroid"},{"key":"R148-6-20210203","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0002-9149(94)90242-9","article-title":"Human experience with amiodarone in the embryonic period.","volume":"73","author":"Ovadia","year":"1994","journal-title":"Am J Cardiol"},{"key":"R149-6-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0892-0362(98)00052-X","article-title":"Neurodevelopment after in utero amiodarone exposure.","volume":"21","author":"Magee","year":"1999","journal-title":"Neurotoxicol Teratol"},{"key":"R150-6-20210203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF03343825","article-title":"Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment.","volume":"24","author":"Bartalena","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"R151-6-20210203","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF03350801","article-title":"Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases.","volume":"21","author":"Grosso","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"R152-6-20210203","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-2007-999467","article-title":"Oral bretylium tosylate use during pregnancy and subsequent breastfeeding: a case report.","volume":"7","author":"Gutgesell","year":"1990","journal-title":"Am J Perinatol"},{"key":"R153-6-20210203","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0196-0644(05)81615-4","article-title":"Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia.","volume":"20","author":"Byerly","year":"1991","journal-title":"Ann Emerg Med"},{"issue":"suppl 3","key":"R154-6-20210203","first-page":"16S","article-title":"Supraventricular tachycardia in pregnancy: cardioversion with verapamil.","volume":"63","author":"Klein","year":"1984","journal-title":"Obstet Gynecol"},{"key":"R155-6-20210203","first-page":"884","article-title":"Treatment of hypertension during pregnancy with the calcium antagonist verapamil.","volume":"39","author":"Orlandi","year":"1986","journal-title":"Curr Ther Res"},{"key":"R156-6-20210203","first-page":"970","article-title":"Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension.","volume":"75","author":"Belfort","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R157-6-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcu.1870220506","article-title":"The effect of acute volume expansion and vasodilatation with verapamil on uterine and umbilical artery Doppler indices in severe preeclampsia.","volume":"22","author":"Belfort","year":"1994","journal-title":"J Clin Ultrasound"},{"key":"R158-6-20210203","first-page":"125","article-title":"Inhibition of myometrial hyperactivity by Ca antagonists.","volume":"26","author":"Ulmsten","year":"1979","journal-title":"Dan Med Bull"},{"key":"R159-6-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000263745","article-title":"Hemodynamic changes during cardioversion in utero: a case report of supraventricular tachycardia and atrial flutter.","volume":"8","author":"Kanzaki","year":"1993","journal-title":"Fetal Diagn Ther"},{"key":"R160-6-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcu.1870130406","article-title":"Treatment of fetal supraventricular tachyarrhythmias.","volume":"13","author":"Kleinman","year":"1985","journal-title":"J Clin Ultrasound"},{"key":"R161-6-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00543804","article-title":"Excretion of verapamil in human milk.","volume":"25","author":"Andersen","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"R162-6-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00614209","article-title":"Verapamil and breast-feeding.","volume":"30","author":"Miller","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R163-6-20210203","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF00543507","article-title":"Level of verapamil in human milk.","volume":"26","author":"Inoue","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"R164-6-20210203","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9378(88)80015-2","article-title":"Tocolytic and cardiovascular effects of the calcium antagonist diltiazem in the near-term pregnant rabbit.","volume":"159","author":"Holbrook","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"R165-6-20210203","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1476-5381.1987.tb11271.x","article-title":"Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects.","volume":"91","author":"Downing","year":"1987","journal-title":"Br J Pharmacol"},{"key":"R166-6-20210203","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198504113121516","article-title":"Excretion of diltiazem in human milk.","volume":"312","author":"Okada","year":"1985","journal-title":"N Engl J Med"},{"key":"R167-6-20210203","first-page":"105","article-title":"Cardiovascular Pharmacotherapeutics, 2nd ed.","author":"Frishman","year":"2003"},{"key":"R168-6-20210203","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00006250-199404000-00024","article-title":"Nifedipine and its indications in obstetrics and gynecology.","volume":"83","author":"Childress","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R169-6-20210203","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0002-9149(93)90590-9","article-title":"Successful management of labor and delivery in primary pulmonary hypertension.","volume":"71","author":"Nootens","year":"1993","journal-title":"Am J Cardiol"},{"key":"R170-6-20210203","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00006250-199011000-00016","article-title":"Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveform.","volume":"76","author":"Pirhonen","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R171-6-20210203","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/0002-9378(89)90915-0","article-title":"Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labor.","volume":"161","author":"Mari","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R172-6-20210203","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/0002-9378(90)90762-V","article-title":"The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term.","volume":"163","author":"Moretti","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R173-6-20210203","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1471-0528.1988.tb06818.x","article-title":"The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy.","volume":"96","author":"Lindow","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"R174-6-20210203","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/j.1875-9114.1992.tb04505.x","article-title":"Oral nifedipine pharmacokinetics in pregnancy-induced hypertension.","volume":"12","author":"Prevost","year":"1992","journal-title":"Pharmacotherapy"},{"key":"R175-6-20210203","first-page":"231","article-title":"Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine.","volume":"11","author":"Manninen","year":"1991","journal-title":"Int J Clin Pharmacol Res"},{"key":"R176-6-20210203","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/0002-9378(89)90909-5","article-title":"Nifedipine pharmacokinetics during preterm labor tocolysis.","volume":"161","author":"Ferguson","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R177-6-20210203","first-page":"331","article-title":"Nifedipine in the treatment of severe preeclampsia.","volume":"77","author":"Fenakel","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R178-6-20210203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2007-999417","article-title":"Comparison of nifedipine and ritodrine for the treatment of preterm labor.","volume":"8","author":"Bracero","year":"1991","journal-title":"Am J Perinatol"},{"key":"R179-6-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9378(11)90679-6","article-title":"A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome.","volume":"163","author":"Ferguson","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R180-6-20210203","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1471-0528.1993.tb15171.x","article-title":"Nifedipine versus ritodrine for suppression of preterm labor.","volume":"100","author":"Kupferminc","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"R181-6-20210203","first-page":"840","article-title":"Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis.","volume":"97","author":"Tsatsaris","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R182-6-20210203","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00128072-200002060-00002","article-title":"Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?","volume":"2","author":"Khedun","year":"2000","journal-title":"Paediatr Drugs"},{"key":"R183-6-20210203","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000299294","article-title":"Comparison of the effects of nicardipine and nifedipine on isolated human myometrium.","volume":"16","author":"Maigaard","year":"1983","journal-title":"Gynecol Obstet Invest"},{"key":"R184-6-20210203","first-page":"908","article-title":"Nicardipine treatment of hypertension during pregnancy.","volume":"81","author":"Carbonne","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R185-6-20210203","first-page":"354","article-title":"Nicardipine versus metoprolol in the treatment o f hypertension during pregnancy: a randomized comparative trial.","volume":"84","author":"Jannet","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R186-6-20210203","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0196-0644(05)82987-7","article-title":"Adenosine use during pregnancy.","volume":"29","author":"Podolsky","year":"1991","journal-title":"Ann Emerg Med"},{"key":"R187-6-20210203","first-page":"478","article-title":"Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia.","volume":"80","author":"Mason","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R188-6-20210203","first-page":"154","article-title":"Use of adenosine for pharmacological cardioversion of SVT in pregnancy.","volume":"5","author":"Chakhtoura","year":"1998","journal-title":"Prim Care"},{"key":"R189-6-20210203","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0735-6757(92)90181-V","article-title":"Adenosine use in pregnancy: lack of effect on fetal heart rate.","volume":"10","author":"Leffler","year":"1992","journal-title":"Am J Emerg Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045415-200407000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:06:25Z","timestamp":1785783985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045415-200407000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":191,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.crd.0000102420.62200.e1","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}